Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/THAT stock hub

AIM/THAT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/THATis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.8M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/THAT

In the news

Latest news · AIM/THAT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-74.2

P25 -54.2P50 2.1P75 13.7

ROIC-49.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/THAT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

GBP

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	4
Employees Change	-1%
Employees Change Percent	-20
Enterprise value	GBX 3.1M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BYW8QM32
Last refreshed	2026-05-10
Market cap	GBX 4.8M
Price	GBX 0.58
Price currency	GBX
Rev Per Employee	1,766.5x
Sector	Healthcare
Sic	2835
Symbol	aim/THAT
Website	https://www.thaliatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.03%
EV Earnings	-2.77x
P/B ratio	2.71x
P/S ratio	677.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	GBX 7,066
Gross Profit Growth	-2.97%
Gross Profit Growth Q	-5.53%
Gross Profit Growth3 Y	53.52%
Net Income	GBX -1.1M
Net Income Growth Years	1%
Pretax Margin	-16,977.24%
Profit Per Employee	GBX -275,576
ROA	-47.21
Roa5y	-46.67
ROCE	-67.97
ROE	-74.18
Roe5y	-71.52
ROIC	-49.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	18.57%
Cagr3y	-33.99%
Cagr5y	-40.94%
EPS Growth Quarters	3
EPS Growth Years	4
Revenue Growth	20.6x
Revenue Growth Q	-5.53x
Revenue Growth Years	1x
Revenue Growth3 Y	53.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0
Assets	GBX 1.8M
Cash	GBX 1.7M
Current Assets	GBX 1.8M
Current Liabilities	GBX 78,367
Equity	GBX 1.8M
Liabilities	GBX 78,367
Long Term Assets	GBX 0
Long Term Liabilities	GBX 0
Net Cash	GBX 1.7M
Net Cash By Market Cap	GBX 36.1
Net Cash Growth	43.37%
Net Debt Equity	GBX -0.98
Tangible Book Value	GBX 1.8M
Tangible Book Value Per Share	GBX 0
WACC	8.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	23.55
Net Working Capital	GBX 39,746
Quick ratio	23.55
Working Capital	GBX 1.8M
Working Capital Turnover	GBX 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-80.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	18.56%
200-day SMA	0.53
3Y total return	-71.25%
50-day SMA	0.52
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.81%
All Time High	35.7
All Time High Change	-98.39%
All Time High Date	2018-02-19
All Time Low	0.35
All Time Low Change	64.29%
All Time Low Date	2025-04-10
ATR	0.06
Beta	0.69
Beta1y	0.37
Beta2y	0.37
Ch YTD	9.52
High	0.6
High52	1
High52 Date	2025-09-22
High52ch	-42.5%
Low	0.55
Low52	0.35
Low52 Date	2025-07-28
Low52ch	64.29%
Ma50ch	11%
Price vs 200-day SMA	8.47%
RSI	62.51
RSI Monthly	43.84
RSI Weekly	56.51
Sharpe ratio	0.47x
Sortino ratio	1.06
Total Return	-80.86%
Tr YTD	9.52
Tr1m	27.78%
Tr3m	21.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -1.2M
Operating margin	-17,000.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	534,465,304%
Shares Insiders	17.46%
Shares Institutions	56.17%
Shares Out	832,280,349
Shares Qo Q	45.46%
Shares Yo Y	80.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,237,952.35x
Bv Per Share	0
Ch1m	27.78
Ch1y	18.56
Ch3m	21.05
Ch3y	-71.25
Ch5y	-92.81
Ch6m	-8
Change	0%
Change From Open	4.55
Close	0.58
Days Gap	-4.35
Dollar Volume	3,557,096.1
Earnings Date	2026-06-25
EBIT	GBX -1.2M
EPS	GBX -0
F Score	2
Financing CF	1,547,595
Fiscal Year End	December
Founded	1,979
Income Tax	GBX -69,733
Is Primary Listing	1
Last Report Date	2025-06-30
Ma150	0.54
Ma150ch	7.08%
Ma20	0.58
Ma20ch	-0.21%
Net CF	522,597
Next Earnings Date	2026-06-25
Open	0.55
Position In Range	50
Price Date	2026-05-07
Ptbv Ratio	2.71
Relative Volume	2.75x
Revenue	7,066x
SBC By Revenue	1,020.29x
Share Based Comp	72,094
Tax By Revenue	-986.88x
Tr6m	-8%
Volume	6,186,254
Z Score	9.87

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/THAT pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/THAT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/THAT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+56.2%

Share of float held by funds and institutions

Insider ownership

+17.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+80.9%

Negative means the company is buying back shares.

Technical

AIM/THAT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.5

Neutral momentum band

Price vs 200-day MA

+8.5%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/THAT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/THAT stock rating?

aim/THAT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/THAT analysis?

The full report lives at /stocks/aim/THAT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/THAT?

The latest report frames aim/THAT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/THAT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.